Yvonne Denno

This inventor holds 10 USPTO granted patents and 2 published patent applications and 7 EPO patents. Top assignees: Euroimmun Medizinische Labordiagnostika Ag, Mayo Foundation for Medical Education and Research. Active years: 2018-2024.

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 90.0

EPO Patents = 7 (Patent Applications = 13)

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 18(Granted Patents)

Location History:

Lübeck, DE (2019 - 2022)
Luebeck, DE (2018 - 2023)

Company Filing History:

10 out of 82

Euroimmun Medizinische Labordiagnostika Ag

patents

1 out of 1,808

Mayo Foundation for Medical Education and Research

patents

where one patent can have more than one assignee

Years Active: 2018-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12174186 - Method and reagents for the detection of an autoantibody (2024-12-24),

2. 11835519 - Autoantibodies to Septin-7 and diagnosis of neurological disease (2023-12-05),

3. 11371991 - Diagnosis of a neuroautoimmune disease (2022-06-28),

4. 11112407 - Diagnosis of a neurological disease (2021-09-07),

5. 10989712 - Diagnosis of a neuroautoimmune disease (2021-04-27),

6. 10842865 - Macadamia allergen (2020-11-24),

7. 10725035 - Diagnosis of a neuroautoimmune disease (2020-07-28),

8. 10466239 - Diagnosis of a neuroautoimmune disease (2019-11-05),

9. 10138285 - Diagnosis of a neuroautoimmune disease comprising measuring autoantibodies to flotillin1 and/or flotillin2 (2018-11-27),

10. 10112982 - Detection of anti-neurochondrin autoantibody in patients with cerebellar ataxia or cerebellitis (2018-10-30),

Title: Yvonne Denno: Innovator in Neurological Diagnostics

Introduction

Yvonne Denno is a prominent inventor based in Lübeck, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the detection of autoantibodies related to neurological diseases and cancers. With a total of 10 patents to her name, her work has the potential to impact the diagnosis and treatment of various medical conditions.

Latest Patents

Among her latest patents is a method and reagents for the detection of an autoantibody that specifically binds to a mammalian VGLUT. This innovative method involves detecting an autoantibody in a sample, which can be crucial for diagnosing neurological autoimmune diseases or cancers. Another notable patent focuses on the autoantibodies to Septin-7, providing a method for diagnosing diseases by detecting an autoantibody binding to Septin-7 in patient samples. This patent also includes the development of a kit that can facilitate the diagnosis of such diseases.

Career Highlights

Yvonne has worked with Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. Her experience in this company has allowed her to develop and refine her innovative diagnostic methods.

Collaborations

Yvonne has collaborated with notable colleagues such as Ramona Miske and Lars Komorowski, contributing to her research and development efforts in the field of medical diagnostics.

Conclusion

Yvonne Denno's work exemplifies the intersection of innovation and healthcare, showcasing her dedication to improving diagnostic methods for neurological diseases. Her contributions continue to pave the way for advancements in medical technology and patient care.